Osimitib (Osimertinib) 80mg*30 | Laos Alliance Generic | GLT

Generic Information: Osimitib (Osimertinib) 80mg — Laos Alliance

Osimitib is the osimertinib generic produced by Laos Alliance Pharmaceutical Group Co., Ltd., a manufacturer based in the Saysettha Development Zone of Vientiane, Lao PDR. The product is registered in Laos (registration number 03 L 0953/23) and is supplied as 80 mg film-coated tablets in 30-tablet bottles. Laos Alliance is one of the larger pharmaceutical enterprises in Laos, operating under Lao GMP standards and positioning "made in Laos" medicines as an affordable alternative to imported brands.

For international buyers, Osimitib represents a Lao-sourced generic of a globally essential lung-cancer medicine. The manufacturer's official product page confirms the strength (80 mg), pack size (30 tablets/bottle) and indication (EGFR-mutated NSCLC), which makes batch verification straightforward.

What Is Osimitib Used For?

Osimitib is used to treat EGFR mutation-positive non-small cell lung cancer. It covers the same clinical settings as the originator: first-line therapy for advanced EGFR-mutant NSCLC, adjuvant therapy after surgery for early-stage disease, and treatment of T790M-positive disease after failure of an earlier EGFR TKI. Its activity against central nervous system metastases is a key reason oncologists favour this class of drug.

How Does Osimitib Work?

Osimitib's active ingredient, osimertinib, is an irreversible inhibitor of mutated epidermal growth factor receptor. It selectively blocks EGFR with exon 19 deletions, L858R mutations and the T790M resistance mutation, while largely sparing normal EGFR. This dual coverage is what allows it to work both as a first-line therapy and after resistance to earlier-generation TKIs develops.

Indications

• EGFR-mutant advanced NSCLC, first-line.
• Adjuvant treatment after resection of EGFR-mutant NSCLC.
• T790M-positive NSCLC following prior EGFR-TKI therapy.

Dosage and Administration

The recommended dose of Osimitib is one 80 mg tablet once daily. It can be taken with or without food. Patients should take the tablet whole with water and should not split or crush it. The prescribing physician may reduce the dose to 40 mg daily to manage side effects, and treatment continues until progression or intolerable toxicity.

Side Effects

The most frequently reported side effects are diarrhoea, skin rash, dry skin, nail toxicity, stomatitis and tiredness. Interstitial lung disease and QT prolongation are rare but serious, so new respiratory symptoms or palpitations should be reported immediately. Regular monitoring of liver enzymes and cardiac function is recommended.

Storage

Keep Osimitib below 30°C, in a dry place, inside the original bottle and out of children's reach. Use before the expiry date shown on the label.

Why Choose the GLT?

GLT works directly with Lao manufacturers and verifies each Osimitib batch against its registration and packaging, so you receive a documented product rather than an unverifiable resale. Lao generics of osimertinib are typically priced at a fraction of the branded product sold in Europe and North America — commonly several times lower — which helps patients and institutions sustain long-term therapy. We provide transparent documentation and responsive support throughout ordering and delivery.

How to Order Osimitib from GLT

Message GLT on WhatsApp at +86 15234153837 or email [email protected] to order Osimitib 80 mg (30 tablets). Provide your required quantity, delivery country and whether the order is for personal or institutional use. We confirm availability, batch documentation and shipping terms before you commit.

FAQ

Where is Osimitib manufactured? Osimitib is manufactured by Laos Alliance Pharmaceutical Group Co., Ltd. in Vientiane, Lao PDR.

Is Osimitib a genuine generic? Yes — it is a registered Lao generic of osimertinib (registration 03 L 0953/23) with the same active ingredient and dose as Tagrisso.

Can I order Osimitib online? Yes, GLT supplies Osimitib internationally; contact us via WhatsApp or email for current availability and shipping options.